Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Non Invasive Colon Cancer Screening Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Fecal Immunochemical Test (FIT)
1.2.3 Guaiac-based Fecal Occult Blood Test (gFOBT)
1.3 Market by Application
1.3.1 Global Non Invasive Colon Cancer Screening Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Speciality Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Diagnostic Centers
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Non Invasive Colon Cancer Screening Market Perspective (2018-2033)
2.2 Non Invasive Colon Cancer Screening Growth Trends by Region
2.2.1 Global Non Invasive Colon Cancer Screening Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Non Invasive Colon Cancer Screening Historic Market Size by Region (2018-2023)
2.2.3 Non Invasive Colon Cancer Screening Forecasted Market Size by Region (2024-2033)
2.3 Non Invasive Colon Cancer Screening Market Dynamics
2.3.1 Non Invasive Colon Cancer Screening Industry Trends
2.3.2 Non Invasive Colon Cancer Screening Market Drivers
2.3.3 Non Invasive Colon Cancer Screening Market Challenges
2.3.4 Non Invasive Colon Cancer Screening Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Non Invasive Colon Cancer Screening Players by Revenue
3.1.1 Global Top Non Invasive Colon Cancer Screening Players by Revenue (2018-2023)
3.1.2 Global Non Invasive Colon Cancer Screening Revenue Market Share by Players (2018-2023)
3.2 Global Non Invasive Colon Cancer Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Non Invasive Colon Cancer Screening Revenue
3.4 Global Non Invasive Colon Cancer Screening Market Concentration Ratio
3.4.1 Global Non Invasive Colon Cancer Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Non Invasive Colon Cancer Screening Revenue in 2022
3.5 Non Invasive Colon Cancer Screening Key Players Head office and Area Served
3.6 Key Players Non Invasive Colon Cancer Screening Product Solution and Service
3.7 Date of Enter into Non Invasive Colon Cancer Screening Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Non Invasive Colon Cancer Screening Breakdown Data by Type
4.1 Global Non Invasive Colon Cancer Screening Historic Market Size by Type (2018-2023)
4.2 Global Non Invasive Colon Cancer Screening Forecasted Market Size by Type (2024-2033)
5 Non Invasive Colon Cancer Screening Breakdown Data by Application
5.1 Global Non Invasive Colon Cancer Screening Historic Market Size by Application (2018-2023)
5.2 Global Non Invasive Colon Cancer Screening Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Non Invasive Colon Cancer Screening Market Size (2018-2033)
6.2 North America Non Invasive Colon Cancer Screening Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Non Invasive Colon Cancer Screening Market Size by Country (2018-2023)
6.4 North America Non Invasive Colon Cancer Screening Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Non Invasive Colon Cancer Screening Market Size (2018-2033)
7.2 Europe Non Invasive Colon Cancer Screening Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Non Invasive Colon Cancer Screening Market Size by Country (2018-2023)
7.4 Europe Non Invasive Colon Cancer Screening Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Non Invasive Colon Cancer Screening Market Size (2018-2033)
8.2 Asia-Pacific Non Invasive Colon Cancer Screening Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Non Invasive Colon Cancer Screening Market Size by Region (2018-2023)
8.4 Asia-Pacific Non Invasive Colon Cancer Screening Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Non Invasive Colon Cancer Screening Market Size (2018-2033)
9.2 Latin America Non Invasive Colon Cancer Screening Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Non Invasive Colon Cancer Screening Market Size by Country (2018-2023)
9.4 Latin America Non Invasive Colon Cancer Screening Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Non Invasive Colon Cancer Screening Market Size (2018-2033)
10.2 Middle East & Africa Non Invasive Colon Cancer Screening Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Non Invasive Colon Cancer Screening Market Size by Country (2018-2023)
10.4 Middle East & Africa Non Invasive Colon Cancer Screening Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Non Invasive Colon Cancer Screening Introduction
11.1.4 Abbott Laboratories Revenue in Non Invasive Colon Cancer Screening Business (2018-2023)
11.1.5 Abbott Laboratories Recent Development
11.2 Beckman Coulter, Inc.
11.2.1 Beckman Coulter, Inc. Company Detail
11.2.2 Beckman Coulter, Inc. Business Overview
11.2.3 Beckman Coulter, Inc. Non Invasive Colon Cancer Screening Introduction
11.2.4 Beckman Coulter, Inc. Revenue in Non Invasive Colon Cancer Screening Business (2018-2023)
11.2.5 Beckman Coulter, Inc. Recent Development
11.3 Epigenomics AG
11.3.1 Epigenomics AG Company Detail
11.3.2 Epigenomics AG Business Overview
11.3.3 Epigenomics AG Non Invasive Colon Cancer Screening Introduction
11.3.4 Epigenomics AG Revenue in Non Invasive Colon Cancer Screening Business (2018-2023)
11.3.5 Epigenomics AG Recent Development
11.4 Sysmex Corporation
11.4.1 Sysmex Corporation Company Detail
11.4.2 Sysmex Corporation Business Overview
11.4.3 Sysmex Corporation Non Invasive Colon Cancer Screening Introduction
11.4.4 Sysmex Corporation Revenue in Non Invasive Colon Cancer Screening Business (2018-2023)
11.4.5 Sysmex Corporation Recent Development
11.5 Quest Diagnostics
11.5.1 Quest Diagnostics Company Detail
11.5.2 Quest Diagnostics Business Overview
11.5.3 Quest Diagnostics Non Invasive Colon Cancer Screening Introduction
11.5.4 Quest Diagnostics Revenue in Non Invasive Colon Cancer Screening Business (2018-2023)
11.5.5 Quest Diagnostics Recent Development
11.6 Exact Sciences Corporation
11.6.1 Exact Sciences Corporation Company Detail
11.6.2 Exact Sciences Corporation Business Overview
11.6.3 Exact Sciences Corporation Non Invasive Colon Cancer Screening Introduction
11.6.4 Exact Sciences Corporation Revenue in Non Invasive Colon Cancer Screening Business (2018-2023)
11.6.5 Exact Sciences Corporation Recent Development
11.7 Novigenix SA
11.7.1 Novigenix SA Company Detail
11.7.2 Novigenix SA Business Overview
11.7.3 Novigenix SA Non Invasive Colon Cancer Screening Introduction
11.7.4 Novigenix SA Revenue in Non Invasive Colon Cancer Screening Business (2018-2023)
11.7.5 Novigenix SA Recent Development
11.8 CML Healthcare, Inc.
11.8.1 CML Healthcare, Inc. Company Detail
11.8.2 CML Healthcare, Inc. Business Overview
11.8.3 CML Healthcare, Inc. Non Invasive Colon Cancer Screening Introduction
11.8.4 CML Healthcare, Inc. Revenue in Non Invasive Colon Cancer Screening Business (2018-2023)
11.8.5 CML Healthcare, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Non Invasive Colon Cancer Screening Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Fecal Immunochemical Test (FIT)
Table 3. Key Players of Guaiac-based Fecal Occult Blood Test (gFOBT)
Table 4. Global Non Invasive Colon Cancer Screening Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Non Invasive Colon Cancer Screening Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Non Invasive Colon Cancer Screening Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Non Invasive Colon Cancer Screening Market Share by Region (2018-2023)
Table 8. Global Non Invasive Colon Cancer Screening Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Non Invasive Colon Cancer Screening Market Share by Region (2024-2033)
Table 10. Non Invasive Colon Cancer Screening Market Trends
Table 11. Non Invasive Colon Cancer Screening Market Drivers
Table 12. Non Invasive Colon Cancer Screening Market Challenges
Table 13. Non Invasive Colon Cancer Screening Market Restraints
Table 14. Global Non Invasive Colon Cancer Screening Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Non Invasive Colon Cancer Screening Market Share by Players (2018-2023)
Table 16. Global Top Non Invasive Colon Cancer Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non Invasive Colon Cancer Screening as of 2022)
Table 17. Ranking of Global Top Non Invasive Colon Cancer Screening Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Non Invasive Colon Cancer Screening Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Non Invasive Colon Cancer Screening Product Solution and Service
Table 21. Date of Enter into Non Invasive Colon Cancer Screening Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Non Invasive Colon Cancer Screening Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Non Invasive Colon Cancer Screening Revenue Market Share by Type (2018-2023)
Table 25. Global Non Invasive Colon Cancer Screening Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Non Invasive Colon Cancer Screening Revenue Market Share by Type (2024-2033)
Table 27. Global Non Invasive Colon Cancer Screening Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Non Invasive Colon Cancer Screening Revenue Market Share by Application (2018-2023)
Table 29. Global Non Invasive Colon Cancer Screening Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Non Invasive Colon Cancer Screening Revenue Market Share by Application (2024-2033)
Table 31. North America Non Invasive Colon Cancer Screening Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Non Invasive Colon Cancer Screening Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Non Invasive Colon Cancer Screening Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Non Invasive Colon Cancer Screening Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Non Invasive Colon Cancer Screening Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Non Invasive Colon Cancer Screening Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Non Invasive Colon Cancer Screening Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Non Invasive Colon Cancer Screening Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Non Invasive Colon Cancer Screening Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Non Invasive Colon Cancer Screening Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Non Invasive Colon Cancer Screening Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Non Invasive Colon Cancer Screening Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Non Invasive Colon Cancer Screening Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Non Invasive Colon Cancer Screening Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Non Invasive Colon Cancer Screening Market Size by Country (2024-2033) & (US$ Million)
Table 46. Abbott Laboratories Company Detail
Table 47. Abbott Laboratories Business Overview
Table 48. Abbott Laboratories Non Invasive Colon Cancer Screening Product
Table 49. Abbott Laboratories Revenue in Non Invasive Colon Cancer Screening Business (2018-2023) & (US$ Million)
Table 50. Abbott Laboratories Recent Development
Table 51. Beckman Coulter, Inc. Company Detail
Table 52. Beckman Coulter, Inc. Business Overview
Table 53. Beckman Coulter, Inc. Non Invasive Colon Cancer Screening Product
Table 54. Beckman Coulter, Inc. Revenue in Non Invasive Colon Cancer Screening Business (2018-2023) & (US$ Million)
Table 55. Beckman Coulter, Inc. Recent Development
Table 56. Epigenomics AG Company Detail
Table 57. Epigenomics AG Business Overview
Table 58. Epigenomics AG Non Invasive Colon Cancer Screening Product
Table 59. Epigenomics AG Revenue in Non Invasive Colon Cancer Screening Business (2018-2023) & (US$ Million)
Table 60. Epigenomics AG Recent Development
Table 61. Sysmex Corporation Company Detail
Table 62. Sysmex Corporation Business Overview
Table 63. Sysmex Corporation Non Invasive Colon Cancer Screening Product
Table 64. Sysmex Corporation Revenue in Non Invasive Colon Cancer Screening Business (2018-2023) & (US$ Million)
Table 65. Sysmex Corporation Recent Development
Table 66. Quest Diagnostics Company Detail
Table 67. Quest Diagnostics Business Overview
Table 68. Quest Diagnostics Non Invasive Colon Cancer Screening Product
Table 69. Quest Diagnostics Revenue in Non Invasive Colon Cancer Screening Business (2018-2023) & (US$ Million)
Table 70. Quest Diagnostics Recent Development
Table 71. Exact Sciences Corporation Company Detail
Table 72. Exact Sciences Corporation Business Overview
Table 73. Exact Sciences Corporation Non Invasive Colon Cancer Screening Product
Table 74. Exact Sciences Corporation Revenue in Non Invasive Colon Cancer Screening Business (2018-2023) & (US$ Million)
Table 75. Exact Sciences Corporation Recent Development
Table 76. Novigenix SA Company Detail
Table 77. Novigenix SA Business Overview
Table 78. Novigenix SA Non Invasive Colon Cancer Screening Product
Table 79. Novigenix SA Revenue in Non Invasive Colon Cancer Screening Business (2018-2023) & (US$ Million)
Table 80. Novigenix SA Recent Development
Table 81. CML Healthcare, Inc. Company Detail
Table 82. CML Healthcare, Inc. Business Overview
Table 83. CML Healthcare, Inc. Non Invasive Colon Cancer Screening Product
Table 84. CML Healthcare, Inc. Revenue in Non Invasive Colon Cancer Screening Business (2018-2023) & (US$ Million)
Table 85. CML Healthcare, Inc. Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Non Invasive Colon Cancer Screening Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Non Invasive Colon Cancer Screening Market Share by Type: 2022 VS 2033
Figure 3. Fecal Immunochemical Test (FIT) Features
Figure 4. Guaiac-based Fecal Occult Blood Test (gFOBT) Features
Figure 5. Global Non Invasive Colon Cancer Screening Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Non Invasive Colon Cancer Screening Market Share by Application: 2022 VS 2033
Figure 7. Hospitals Case Studies
Figure 8. Speciality Clinics Case Studies
Figure 9. Ambulatory Surgical Centers Case Studies
Figure 10. Diagnostic Centers Case Studies
Figure 11. Others Case Studies
Figure 12. Non Invasive Colon Cancer Screening Report Years Considered
Figure 13. Global Non Invasive Colon Cancer Screening Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Non Invasive Colon Cancer Screening Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Non Invasive Colon Cancer Screening Market Share by Region: 2022 VS 2033
Figure 16. Global Non Invasive Colon Cancer Screening Market Share by Players in 2022
Figure 17. Global Top Non Invasive Colon Cancer Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non Invasive Colon Cancer Screening as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Non Invasive Colon Cancer Screening Revenue in 2022
Figure 19. North America Non Invasive Colon Cancer Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Non Invasive Colon Cancer Screening Market Share by Country (2018-2033)
Figure 21. United States Non Invasive Colon Cancer Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Non Invasive Colon Cancer Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Non Invasive Colon Cancer Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Non Invasive Colon Cancer Screening Market Share by Country (2018-2033)
Figure 25. Germany Non Invasive Colon Cancer Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. France Non Invasive Colon Cancer Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. U.K. Non Invasive Colon Cancer Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Italy Non Invasive Colon Cancer Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Russia Non Invasive Colon Cancer Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Nordic Countries Non Invasive Colon Cancer Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Non Invasive Colon Cancer Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Non Invasive Colon Cancer Screening Market Share by Region (2018-2033)
Figure 33. China Non Invasive Colon Cancer Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Japan Non Invasive Colon Cancer Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. South Korea Non Invasive Colon Cancer Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Southeast Asia Non Invasive Colon Cancer Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. India Non Invasive Colon Cancer Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Australia Non Invasive Colon Cancer Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Non Invasive Colon Cancer Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Non Invasive Colon Cancer Screening Market Share by Country (2018-2033)
Figure 41. Mexico Non Invasive Colon Cancer Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Brazil Non Invasive Colon Cancer Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Non Invasive Colon Cancer Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Non Invasive Colon Cancer Screening Market Share by Country (2018-2033)
Figure 45. Turkey Non Invasive Colon Cancer Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Saudi Arabia Non Invasive Colon Cancer Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Abbott Laboratories Revenue Growth Rate in Non Invasive Colon Cancer Screening Business (2018-2023)
Figure 48. Beckman Coulter, Inc. Revenue Growth Rate in Non Invasive Colon Cancer Screening Business (2018-2023)
Figure 49. Epigenomics AG Revenue Growth Rate in Non Invasive Colon Cancer Screening Business (2018-2023)
Figure 50. Sysmex Corporation Revenue Growth Rate in Non Invasive Colon Cancer Screening Business (2018-2023)
Figure 51. Quest Diagnostics Revenue Growth Rate in Non Invasive Colon Cancer Screening Business (2018-2023)
Figure 52. Exact Sciences Corporation Revenue Growth Rate in Non Invasive Colon Cancer Screening Business (2018-2023)
Figure 53. Novigenix SA Revenue Growth Rate in Non Invasive Colon Cancer Screening Business (2018-2023)
Figure 54. CML Healthcare, Inc. Revenue Growth Rate in Non Invasive Colon Cancer Screening Business (2018-2023)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed